Inventor
MICHAL EUGENE T
US68 patents
⚠️ This page may combine multiple inventors who share the name “MICHAL EUGENE T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADVANCED CARDIOVASCULAR SYSTEM
20 patentsUS7294334B1Nov 13, 2007
Methods and compositions to treat myocardial conditions
ADVANCED CARDIOVASCULAR SYSTEM161 citations99
US7776926B1Aug 17, 2010
Biocompatible coating for implantable medical devices
ADVANCED CARDIOVASCULAR SYSTEM71 citations98
US7247313B2Jul 24, 2007
Polyacrylates coatings for implantable medical devices
ADVANCED CARDIOVASCULAR SYSTEM162 citations98
US6994867B1Feb 7, 2006
Biocompatible carrier containing L-arginine
ADVANCED CARDIOVASCULAR SYSTEM123 citations98
US6702744B2Mar 9, 2004
Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
ADVANCED CARDIOVASCULAR SYSTEM129 citations98
US6656517B2Dec 2, 2003
Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
ADVANCED CARDIOVASCULAR SYSTEM120 citations98
US6541116B2Apr 1, 2003
Superoxide dismutase or superoxide dismutase mimic coating for an intracorporeal medical device
ADVANCED CARDIOVASCULAR SYSTEM153 citations98
US6287285B1Sep 11, 2001
Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device
ADVANCED CARDIOVASCULAR SYSTEM419 citations98
US7094256B1Aug 22, 2006
Coatings for implantable medical device containing polycationic peptides
ADVANCED CARDIOVASCULAR SYSTEM113 citations96
US7070798B1Jul 4, 2006
Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
ADVANCED CARDIOVASCULAR SYSTEM55 citations96
US7033602B1Apr 25, 2006
Polycationic peptide coatings and methods of coating implantable medical devices
ADVANCED CARDIOVASCULAR SYSTEM30 citations96
US6221425B1Apr 24, 2001
Lubricious hydrophilic coating for an intracorporeal medical device
ADVANCED CARDIOVASCULAR SYSTEM112 citations94
US7378106B2May 27, 2008
Biologically absorbable coatings for implantable devices and methods for fabricating the same
ADVANCED CARDIOVASCULAR SYSTEM28 citations93
US7056523B1Jun 6, 2006
Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
ADVANCED CARDIOVASCULAR SYSTEM24 citations93
US7919075B1Apr 5, 2011
Coatings for implantable medical devices
ADVANCED CARDIOVASCULAR SYSTEM13 citations92
US7682669B1Mar 23, 2010
Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
ADVANCED CARDIOVASCULAR SYSTEM16 citations92
US6793960B1Sep 21, 2004
Medical device having surface modification with superoxide dismutase mimic
ADVANCED CARDIOVASCULAR SYSTEM24 citations92
US7854944B2Dec 21, 2010
Tissue regeneration
ADVANCED CARDIOVASCULAR SYSTEM12 citations84
US7470469B1Dec 30, 2008
Medical device having surface modification with superoxide dismutase mimic
ADVANCED CARDIOVASCULAR SYSTEM6 citations73
US8003123B2Aug 23, 2011
Biologically absorbable coatings for implantable devices and methods for fabricating the same
ADVANCED CARDIOVASCULAR SYSTEM4 citations63
MICHAL EUGENE T
10 patentsUS8114429B2Feb 14, 2012
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
MICHAL EUGENE T35 citations96
US8257722B2Sep 4, 2012
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
MICHAL EUGENE T38 citations95
US8673332B2Mar 18, 2014
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
MICHAL EUGENE T16 citations92
US8563023B2Oct 22, 2013
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
MICHAL EUGENE T30 citations92
US8491925B2Jul 23, 2013
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
MICHAL EUGENE T22 citations92
US8128951B2Mar 6, 2012
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
MICHAL EUGENE T25 citations92
US8303972B2Nov 6, 2012
Hydrogel bioscaffoldings and biomedical device coatings
MICHAL EUGENE T17 citations84
US9198968B2Dec 1, 2015
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
MICHAL EUGENE T13 citations83
US9005672B2Apr 14, 2015
Methods of modifying myocardial infarction expansion
MICHAL EUGENE T7 citations82
US8795652B1Aug 5, 2014
Methods and compositions to treat myocardial conditions
MICHAL EUGENE T2 citations63
SPECTRANETICS CORP
5 patentsUS10117970B2Nov 6, 2018
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
SPECTRANETICS CORP13 citations92
US9603973B2Mar 28, 2017
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
SPECTRANETICS CORP3 citations84
US10314948B2Jun 11, 2019
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
SPECTRANETICS CORP9 citations83
US10046093B2Aug 14, 2018
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
SPECTRANETICS CORP11 citations83
US10987452B2Apr 27, 2021
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
SPECTRANETICS CORP1 citations72
ABBOTT CARDIOVASCULAR SYSTEMS
3 patentsUS7641643B2Jan 5, 2010
Methods and compositions to treat myocardial conditions
ABBOTT CARDIOVASCULAR SYSTEMS51 citations95
US8383158B2Feb 26, 2013
Methods and compositions to treat myocardial conditions
ABBOTT CARDIOVASCULAR SYSTEMS15 citations92
US7311970B2Dec 25, 2007
Medical device having surface modification with superoxide dismutase mimic
ABBOTT CARDIOVASCULAR SYSTEMS11 citations84
COVIDIEN LP
3 patentsUS9132211B2Sep 15, 2015
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
COVIDIEN LP11 citations92
US9034362B2May 19, 2015
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
COVIDIEN LP16 citations92
US8734825B2May 27, 2014
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
COVIDIEN LP13 citations92
MANDRUSOV EVGENIA
2 patentsABBOTT CARDIOVASCULAR SYSTEMS INC
2 patentsUS9775930B2Oct 3, 2017
Composition for modifying myocardial infarction expansion
ABBOTT CARDIOVASCULAR SYSTEMS INC16 citations90
US9656030B1May 23, 2017
System for the injection of cells and/or biologically active materials into coronary arteries for therapeutic purposes
ABBOTT CARDIOVASCULAR SYSTEMS INC17 citations83
ADVANCED CARDIOVASULAR SYSTEMS
1 patentGLAUSER THIERRY
1 patentHOSSAINY SYED FAIYAZ AHMED
1 patentROORDA WOUTER E
1 patentADVANCED CARDIOVASCULAR SYSTEMS INC
1 patentShowing the top 50 of 68 patents by PatentIndex Score.